Inside this Issue

Novo Nordisk

Improves Product Integrity with Simulation

FDA

Recognizes Simulation as Essential to Medical Device Evaluation

Medtronic

Advances Stent Graft Designs

This latest issue of SIMULIA Community News introduces us to how engineers at Novo Nordisk are able to improve the medical field by introducing a new form of injection pens that will assist more than 350 million diabetics worldwide. This invention, made possible by the use of Abaqus, shows the advances the medical field is making by using realistic simulation solutions. Additionally, see how the FDA now recognizes simulation as essential to the evaluation of medical devices, and introduces the ‘Virtual Patient’, and Medtronic helps saves life by improving and introducing new stent graft design which are safer for the patients that are utilizing this product.

We hope you enjoy this issue of SIMULIA Community News!